StockWatch
·
Pharmaceuticals
Board Meeting26 Oct 2026, 03:53 pm

Abbott India Board Meeting on Nov 5 to Approve Q2 FY27 Results

AI Summary

Abbott India has informed BSE that its Board of Directors will convene on November 5, 2026. The primary agenda is to consider and approve the unaudited financial results for the second quarter and half-year ended September 30, 2026. The company also noted that the trading window remains closed from October 1, 2026, to November 7, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve unaudited financial results for Q2 and H1 FY27.
  • Financial period ending September 30, 2026.
  • Trading window closure from October 1 to November 7, 2026.
  • Compliance with SEBI Insider Trading Regulations.